AIM2 and ovarian carcinoma: Ye et al. [12] showed a novel signature of seven PRGs (AIM2, PJVK, PLCG1, GSDMA, ELANE, CASP3, and CASP6) for predicting the prognosis of ovarian cancer (OC).